ASX
Amplia Therapeutics Limited
ATX:ASX•Healthcare
Sensitive ASX Announcement
Phase 2B Trial of MIS416 on Schedule to Complete April 2017
Published: 28/02/17, 08:28am (AEST)•2 pages